MICHAEL ABRAMS

Profile

First Name

: MICHAEL

Middle Name

:

Last Name

: ABRAMS

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
BOND LABORATORIES, INC.
GRANT DAWSON, LEWIS JAFFE, DAYTON JUDD, ELORIAN LANDERS, SCOTT LANDOW, SCOTT D LANDOW, TODD ORDAL, JOHN WILSON, JOHN S. WILSON, SETH YAKATAN
EXECUTIVE OFFICER
SPARTAN BIOSCIENCE INC.
LAWRENCE D-ANDREA, MARK HOUGHTING, MARK KERSHEY, JOHN LEM, PAUL LEM, PAUL MARKELL, KEN PAIGE, ALAN SHAYANPOUR, JAMIE SPIEGELMAN, JAMIE SPIEGLEMAN, MICHAEL STORK
EXECUTIVE OFFICER, PROMOTER
CHARLES STREET LAND, LLC
ANDREW MURPHY
EXECUTIVE OFFICER, DIRECTOR
FREELINC TECHNOLOGIES INC.
RICHARD PROPPER
EXECUTIVE OFFICER, DIRECTOR
FITLIFE BRANDS, INC.
GRANT DAWSON, LEWIS JAFFE, DAYTON JUDD, ELORIAN LANDERS, SCOTT LANDOW, SCOTT D LANDOW, TODD ORDAL, JOHN WILSON, JOHN S. WILSON, SETH YAKATAN
DIRECTOR
ATOM TICKETS, LLC
CHRIS ARONSON, MATTHEW BAKAL, ALLISON CHECCHI, NICHOLAS GELLER, JENNIFER HOLLINGSWORTH, AMEESH PALEJA, GEOFFREY SHAEVITZ
DIRECTOR
NERVGEN PHARMA CORP.
MICHAEL JEFFREY ABRAMS, WILLIAM ADAMS, BRIAN BAYLEY, BRIAN ERIC BAYLEY, DENIS BOSC, PAUL BRENNAN, AMY FRANKE, GLENN IVES, RANDALL KAYE, LLOYD MACKENZIE, KRISTA MCKERRACHER, DANIEL MIKOL, ROBERT PILZ, ROBERT GERHARD PILZ, HAROLD PUNNETT, HAROLD MARTIN PUNNETT, BILL RADVAK, WILLIAM JOSEPH RADVAK, ERNEST WONG, ERNEST SHINGYAN WONG
EXECUTIVE OFFICER
NRX PHARMACEUTICALS, INC.
RICHARD ACKERMAN, RICHARD BARDOFF, KIM BENNETT, PATRICK FLYNN, MICHAEL FONG, CHAIM HURVITZ, JONATHAN JAVITT, STUART F. KOENIG, DENNIS MCBRIDE, ALBERT G. REX, MICHAEL TAYLOR, TROY T. TAYLOR, LORI B. WITTMAN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-03-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-01-27 
2021-12-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-29 
2021-08-25
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-10 
2021-08-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-04 
2021-06-02
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-20 
2020-08-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-10 
2020-06-03
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-20 
2019-11-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-15 
2019-03-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-15 
2018-11-27
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$5,000,001 - $25,000,000 
Equity 
2018-11-13 
2015-03-02
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-21 
2014-07-28
D
Link
RESIDENTIAL 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-21 
2013-04-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-17 
2012-05-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-15 
2010-07-12
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$5,000,001 - $25,000,000 
Debt 
2010-06-29 
2009-10-21
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$5,000,001 - $25,000,000 
Equity 
2009-08-11